Alx Oncology Holdings (ALXO) Shares Outstanding (Weighted Average) (2019 - 2026)

Alx Oncology Holdings' Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $104.6 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 95.98% year-over-year to $104.6 million; the TTM figure through Mar 2026 stood at $104.6 million (up 95.98% YoY), while the FY2025 annual figure was $1.2 million, down 97.6% from the prior year.
• Shares Outstanding (Weighted Average) came in at $104.6 million for Q1 2026 at Alx Oncology Holdings, up from $1.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $104.6 million in Q1 2026 to a low of $1.2 million in Q4 2025.
• A 5-year average of $47.0 million and a median of $43.0 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) plunged 97.6% in 2025 and jumped 95.98% in 2026, its largest moves.
• Alx Oncology Holdings' Shares Outstanding (Weighted Average) stood at $40.7 million in 2022, then increased by 5.62% to $43.0 million in 2023, then grew by 21.37% to $52.2 million in 2024, then slumped by 97.6% to $1.2 million in 2025, then surged by 8265.89% to $104.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $104.6 million, $1.2 million, and $53.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison